Literature DB >> 22015985

TCR diversity and Treg cells, sometimes more is more.

James B Wing1, Shimon Sakaguchi.   

Abstract

Treg cells are critical for the maintenance of immune homeostasis and suppression of naturally occurring self-reactive T cells; however, in order to induce suppression Treg cells must first be activated via their T-cell receptor by recognition of specific antigen-MHC complexes. In this issue of the European Journal of Immunology, Föhse et al. [Eur. J. Immunol. 2011. 41: 3101-3113.] shed light on the important question of the role of TCR diversity on Treg-cell function by demonstrating that high TCR diversity is crucial for optimal Treg-cell expansion, peripheral reshaping of the Treg-cell TCR repertoire and in vivo suppressive capacity. In this Commentary, we discuss these findings and also propose a simple mathematical model to aid in the understanding of the relationship between Treg-cell TCR diversity and the level of suppression delivered by Treg cells in vivo.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22015985     DOI: 10.1002/eji.201142115

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

Review 1.  Modeling the T cell immune response: a fascinating challenge.

Authors:  Penelope A Morel; James R Faeder; William F Hawse; Natasa Miskov-Zivanov
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-08-26       Impact factor: 2.745

2.  MHC-derived allopeptide activates TCR-biased CD8+ Tregs and suppresses organ rejection.

Authors:  Elodie Picarda; Séverine Bézie; Vanessa Venturi; Klara Echasserieau; Emmanuel Mérieau; Aurélie Delhumeau; Karine Renaudin; Sophie Brouard; Karine Bernardeau; Ignacio Anegon; Carole Guillonneau
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

Review 3.  Haematopoietic stem cell transplantation for autoimmune diseases.

Authors:  Joost F Swart; Eveline M Delemarre; Femke van Wijk; Jaap-Jan Boelens; Jürgen Kuball; Jacob M van Laar; Nico M Wulffraat
Journal:  Nat Rev Rheumatol       Date:  2017-02-23       Impact factor: 20.543

4.  Characterization of Peripheral Blood TCR in Patients with Type 1 Diabetes Mellitus by BD RhapsodyTM VDJ CDR3 Assay.

Authors:  Takuro Okamura; Masahide Hamaguchi; Hiroyuki Tominaga; Noriyuki Kitagawa; Yoshitaka Hashimoto; Saori Majima; Takafumi Senmaru; Hiroshi Okada; Emi Ushigome; Naoko Nakanishi; Shigeyuki Shichino; Michiaki Fukui
Journal:  Cells       Date:  2022-05-12       Impact factor: 7.666

5.  Bim regulates the survival and suppressive capability of CD8+ FOXP3+ regulatory T cells during murine GVHD.

Authors:  Kimberle Agle; Benjamin G Vincent; Clint Piper; Ludovic Belle; Vivian Zhou; Warren Shlomchik; Jonathan S Serody; William R Drobyski
Journal:  Blood       Date:  2018-05-16       Impact factor: 22.113

6.  Chronic follicular bronchiolitis requires antigen-specific regulatory T cell control to prevent fatal disease progression.

Authors:  Erica G Schmitt; Dipica Haribhai; Jonathan C Jeschke; Dominic O Co; Jennifer Ziegelbauer; Ke Yan; Yoichiro Iwakura; Manoj K Mishra; Pippa Simpson; Nita H Salzman; Calvin B Williams
Journal:  J Immunol       Date:  2013-10-25       Impact factor: 5.422

7.  T cell populations in the pancreatic lymph node naturally and consistently expand and contract in NOD mice as disease progresses.

Authors:  Idania Marrero; Allen Vong; Yang Dai; Joanna D Davies
Journal:  Mol Immunol       Date:  2012-05-10       Impact factor: 4.407

Review 8.  Estimating T-cell repertoire diversity: limitations of classical estimators and a new approach.

Authors:  Daniel J Laydon; Charles R M Bangham; Becca Asquith
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-08-19       Impact factor: 6.237

9.  Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes.

Authors:  Howard R Seay; Erik Yusko; Stephanie J Rothweiler; Lin Zhang; Amanda L Posgai; Martha Campbell-Thompson; Marissa Vignali; Ryan O Emerson; John S Kaddis; Dave Ko; Maki Nakayama; Mia J Smith; John C Cambier; Alberto Pugliese; Mark A Atkinson; Harlan S Robins; Todd M Brusko
Journal:  JCI Insight       Date:  2016-12-08

10.  Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis.

Authors:  Hélène Asnagli; Delphine Martire; Nathalie Belmonte; Julie Quentin; Hervé Bastian; Mathilde Boucard-Jourdin; Papa Babacar Fall; Anne-Laure Mausset-Bonnefont; Amélie Mantello-Moreau; Sandrine Rouquier; Irène Marchetti; Christian Jorgensen; Arnaud Foussat; Pascale Louis-Plence
Journal:  Arthritis Res Ther       Date:  2014-05-22       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.